Looking at the most significantly mutated genes in B-cell and T-cell lymphomas across the three studied breeds, genes not previously implicated in human lymphoma include well-known cancer-associated genes such as LTA4H and PSMA1, indicating potential treatment with proteasome inhibitors. The gene discussed is LTA4H; the disease is T-cell non-Hodgkin lymphoma.